Associated Papers
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.
Weathers SP et al.
Nature Communications, 2025
40289138 (PubMed )
Supplement: 41467_2025_56930_MOESM4_ESM.xlsx › Figure_2c
Select a paper to view details